PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26427870-0	2015	Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/beta-catenin signaling.	Tigecycline	39-50	catenin beta 1	Homo sapiens	110-122	
26427870-2	2015	We show that tigecycline, a FDA-approved antibiotic drug, targets cervical squamous cell carcinoma through inhibiting Wnt/beta-catenin signaling pathway.	Tigecycline	13-24	catenin beta 1	Homo sapiens	122-134	
26427870-6	2015	We further show that tigecycline decreases level of both cytoplasmic and nuclear beta-catenin and suppressed Wnt/beta-catenin-mediated transcription through increasing levels of Axin 1 in Hela cells.	Tigecycline	21-32	catenin beta 1	Homo sapiens	81-93	
26427870-6	2015	We further show that tigecycline decreases level of both cytoplasmic and nuclear beta-catenin and suppressed Wnt/beta-catenin-mediated transcription through increasing levels of Axin 1 in Hela cells.	Tigecycline	21-32	catenin beta 1	Homo sapiens	113-125	
26427870-7	2015	In addition, stabilization or overexpression of beta-catenin using pharmacological and genetic approaches abolished the effects of tigecycline in inhibiting proliferation and inducing apoptosis of Hela cells.	Tigecycline	131-142	catenin beta 1	Homo sapiens	48-60